Abeona Therapeutics, Inc. (ABEO)
6.01
+0.18
(+3.09%)
USD |
NASDAQ |
May 06, 16:00
6.01
0.00 (0.00%)
Pre-Market: 20:00
Abeona Therapeutics Free Cash Flow : -84.30M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Celldex Therapeutics, Inc. | -213.66M |
| Plus Therapeutics, Inc. | -20.84M |
| Atossa Therapeutics, Inc. | -29.78M |
| Cell Source, Inc. | -- |
| Kiora Pharmaceuticals, Inc. | -10.07M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -17.95M |
| Cash from Investing (Quarterly) | 9.554M |
| Cash from Financing (Quarterly) | 3.614M |
| Free Cash Flow Per Share (Quarterly) | -0.3471 |
| Free Cash Flow to Equity (Quarterly) | -19.97M |
| Free Cash Flow to Firm (Quarterly) | -18.23M |
| Free Cash Flow Yield | -24.86% |